Sivik Global Healthcare LLC
In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 1, 2024), Sivik Global Healthcare LLC reported 46 stock positions worth $275.1 million. Its top holding was SS SPDR S&P Biotech ETF (XBI) at 10.3% of the portfolio, followed by Eli Lilly (LLY, 4.5%) and Novo-Nordisk A/S-Spons ADR (NVO, 4.3%). Compared with Q4 2023, it opened 15 new positions, sold out of 8, added to 13 and reduced 16. The biggest buy was SS SPDR S&P Biotech ETF (XBI, shares +121%) and the biggest sale an exit from Medtronic (MDT).
- Most Recent 13F
- Q2 2026
- Location
- GREENWICH, CT
- CIK
- 0001596452
- Portfolio Value
- $275.1M (Q1 2024)
- SEC Filing
- 0001596452-24-000004 ↗ filed May 1, 2024
Holdings Value
Holdings 46 stocks · $275.1M
| XBI SS SPDR S&P Biotech ETF | 10.35% | 300,000 | $28.5M | Add +121.3% |
| LLY Eli Lilly & Co. | 4.52% | 16,000 | $12.4M | Add +6.7% |
| NVO Novo-Nordisk A/S-Spons ADR | 4.32% | 92,500 | $11.9M | Add +2.8% |
| BSX Boston Scientific Corp. | 3.36% | 135,000 | $9.2M | Reduce -15.6% |
| TMO Thermo Fisher Scientific Inc. | 3.28% | 15,500 | $9.0M | Add +29.2% |
| SYK Stryker Corp. | 3.25% | 25,000 | $8.9M | Reduce -10.7% |
| ISRG Intuitive Surgical Inc. | 2.90% | 20,000 | $8.0M | Reduce -11.1% |
| THC Tenet Healthcare Corp. | 2.87% | 75,000 | $7.9M | Reduce -48.3% |
| MCK McKesson Corp. | 2.83% | 14,500 | $7.8M | Reduce -3.3% |
| DHR Danaher Corp. | 2.72% | 30,000 | $7.5M | Add +20.0% |
| UHS Universal Health Services-B | 2.65% | 40,000 | $7.3M | Reduce -40.7% |
| RMD Resmed Inc. | 2.55% | 35,361 | $7.0M | Add +76.8% |
| HUM Humana Inc. | 2.52% | 20,000 | $6.9M | Add +33.3% |
| CRL Charles River Laboratories | 2.46% | 25,000 | $6.8M | New |
| EW Edwards Lifesciences Corp. | 2.43% | 70,000 | $6.7M | New |
| SEM Select Medical Holdings Corp. | 2.19% | 200,000 | $6.0M | Reduce -20.0% |
| INSP Inspire Medical Systems Inc. | 2.15% | 27,500 | $5.9M | No change |
| HCA HCA Healthcare Inc. | 2.12% | 17,500 | $5.8M | Reduce -56.3% |
| ABT Abbott Laboratories | 2.07% | 50,000 | $5.7M | Reduce -4.8% |
| SGRY Surgery Partners Inc. | 2.06% | 190,000 | $5.7M | Reduce -5.0% |
| BAX Baxter International Inc. | 2.02% | 130,000 | $5.6M | New |
| ACHC Acadia Healthcare Co. Inc. | 2.02% | 70,000 | $5.5M | Reduce -22.2% |
| AVTR Avantor Inc. | 1.99% | 213,947 | $5.5M | New |
| SNN Smith & Nephew PLC -Spon ADR | 1.89% | 205,000 | $5.2M | Add +7.9% |
| PODD Insulet Corp. | 1.87% | 30,000 | $5.1M | Add +13.2% |
| CAH Cardinal Health Inc. | 1.83% | 45,000 | $5.0M | Add +12.5% |
| BMRN Biomarin Pharmaceutical Inc. | 1.83% | 57,500 | $5.0M | Add +4.5% |
| EHC Encompass Health Corp. | 1.80% | 60,000 | $5.0M | Reduce -33.3% |
| UNH Unitedhealth Group Inc. | 1.80% | 10,000 | $4.9M | No change |
| DXCM Dexcom Inc. | 1.76% | 35,000 | $4.9M | Reduce -30.0% |
| VRTX Vertex Pharmaceuticals Inc. | 1.67% | 11,000 | $4.6M | Reduce -12.0% |
| WST West Pharmaceutical Services | 1.44% | 10,000 | $4.0M | New |
| BDX Becton Dickinson and Co. | 1.35% | 15,000 | $3.7M | New |
| OPCH Option Care Health Inc. | 1.34% | 110,000 | $3.7M | New |
| GEHC GE Healthcare Technology | 1.32% | 40,000 | $3.6M | New |
| CI The Cigna Group | 1.32% | 10,000 | $3.6M | Reduce -42.9% |
| NTRA Natera Inc. | 1.16% | 35,000 | $3.2M | New |
| MRVI Maravai Lifesciences Hldgs-A | 1.15% | 365,000 | $3.2M | Add +77.8% |
| RVTY Revvity Inc. | 1.15% | 30,000 | $3.1M | New |
| MEDP Medpace Holdings Inc. | 1.10% | 7,500 | $3.0M | New |
| CTLT Catalent Inc. | 1.03% | 50,000 | $2.8M | New |
| STVN Stevanato Group SPA | 0.97% | 83,039 | $2.7M | Add +3.8% |
| TEVA Teva Pharmaceutical-SP ADR | 0.90% | 175,000 | $2.5M | New |
| BNTX Biontech SE-ADR | 0.84% | 25,000 | $2.3M | New |
| BIIB Biogen Inc. | 0.79% | 10,034 | $2.2M | Reduce -59.9% |
| GPCR Structure Therapeutics Inc. | 0.07% | 4,464 | $191K | New |
Options reported separately and not counted above: PUT - SPY 100 @ 505 EXP 04/19/2024 puts ($151.5M).
Portfolio Sells Q4 2023 → Q1 2024
| MDT Medtronic PLC | Sold out | 0.00% | −2.75 |
| ZBH Zimmer Biomet Holdings Inc. | Sold out | 0.00% | −2.54 |
| HCA HCA Healthcare Inc. | Reduce -56.3% | 2.12% | −2.40 |
| DVA Davita Inc. | Sold out | 0.00% | −1.97 |
| BIIB Biogen Inc. | Reduce -59.9% | 0.79% | −1.92 |
| DGX Quest Diagnostics Inc. | Sold out | 0.00% | −1.73 |
| COR Cencora Inc. | Sold out | 0.00% | −1.72 |
| THC Tenet Healthcare Corp. | Reduce -48.3% | 2.87% | −1.71 |
| UHS Universal Health Services-B | Reduce -40.7% | 2.65% | −1.65 |
| LH Laboratory CRP of Amer Hldgs | Sold out | 0.00% | −1.42 |
| QGEN Qiagen NV | Sold out | 0.00% | −1.00 |
| WBA Walgreens Boots Alliance Inc. | Sold out | 0.00% | −0.98 |
| ACHC Acadia Healthcare Co. Inc. | Reduce -22.2% | 2.02% | −0.91 |
| CI The Cigna Group | Reduce -42.9% | 1.32% | −0.87 |
| DXCM Dexcom Inc. | Reduce -30.0% | 1.76% | −0.83 |
| EHC Encompass Health Corp. | Reduce -33.3% | 1.80% | −0.71 |
| SGRY Surgery Partners Inc. | Reduce -5.0% | 2.06% | −0.61 |
| BSX Boston Scientific Corp. | Reduce -15.6% | 3.36% | −0.50 |
| VRTX Vertex Pharmaceuticals Inc. | Reduce -12.0% | 1.67% | −0.45 |
| ABT Abbott Laboratories | Reduce -4.8% | 2.07% | −0.35 |
| ISRG Intuitive Surgical Inc. | Reduce -11.1% | 2.90% | −0.27 |
| SEM Select Medical Holdings Corp. | Reduce -20.0% | 2.19% | −0.26 |
| SYK Stryker Corp. | Reduce -10.7% | 3.25% | −0.25 |
| MCK McKesson Corp. | Reduce -3.3% | 2.83% | −0.07 |
Portfolio Buys Q4 2023 → Q1 2024
| XBI SS SPDR S&P Biotech ETF | Add +121.3% | 10.35% | +5.29 |
| CRL Charles River Laboratories | New | 2.46% | +2.46 |
| EW Edwards Lifesciences Corp. | New | 2.43% | +2.43 |
| BAX Baxter International Inc. | New | 2.02% | +2.02 |
| AVTR Avantor Inc. | New | 1.99% | +1.99 |
| WST West Pharmaceutical Services | New | 1.44% | +1.44 |
| BDX Becton Dickinson and Co. | New | 1.35% | +1.35 |
| OPCH Option Care Health Inc. | New | 1.34% | +1.34 |
| GEHC GE Healthcare Technology | New | 1.32% | +1.32 |
| NTRA Natera Inc. | New | 1.16% | +1.16 |
| RVTY Revvity Inc. | New | 1.15% | +1.15 |
| RMD Resmed Inc. | Add +76.8% | 2.55% | +1.11 |
| MEDP Medpace Holdings Inc. | New | 1.10% | +1.10 |
| CTLT Catalent Inc. | New | 1.03% | +1.03 |
| TEVA Teva Pharmaceutical-SP ADR | New | 0.90% | +0.90 |
| LLY Eli Lilly & Co. | Add +6.7% | 4.52% | +0.87 |
| BNTX Biontech SE-ADR | New | 0.84% | +0.84 |
| TMO Thermo Fisher Scientific Inc. | Add +29.2% | 3.28% | +0.61 |
| MRVI Maravai Lifesciences Hldgs-A | Add +77.8% | 1.15% | +0.59 |
| NVO Novo-Nordisk A/S-Spons ADR | Add +2.8% | 4.32% | +0.43 |
| DHR Danaher Corp. | Add +20.0% | 2.72% | +0.31 |
| CAH Cardinal Health Inc. | Add +12.5% | 1.83% | +0.15 |
| GPCR Structure Therapeutics Inc. | New | 0.07% | +0.07 |
| STVN Stevanato Group SPA | Add +3.8% | 0.97% | +0.06 |
| SNN Smith & Nephew PLC -Spon ADR | Add +7.9% | 1.89% | −0.28 |
| HUM Humana Inc. | Add +33.3% | 2.52% | −0.35 |
| BMRN Biomarin Pharmaceutical Inc. | Add +4.5% | 1.83% | −0.39 |
| PODD Insulet Corp. | Add +13.2% | 1.87% | −0.53 |
Options Activity Q4 2023 → Q1 2024
| PUT - SPY 100 @ 505 EXP 04/19/2024 | put | New | 3,000 | $151.5M |
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 34 | $131.7M | XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK |
| Q1 2026 | 34 | $131.7M | XBI, CAH, CALL- BSX 100 @ 75 EXP 04/17/2026, JNJ, MRK |
| Q4 2025 | 41 | $204.8M | XBI, LLY, THC, MCK, HCA |
| Q3 2025 | 35 | $190.5M | XBI, LLY, HCA, THC, DHR |
| Q2 2025 | 38 | $223.6M | XBI, THC, HCA, MCK, UHS |
| Q1 2025 | 29 | $182.9M | XBI, BSX, THC, HCA, LLY |
| Q4 2024 | 36 | $180.8M | XBI, LLY, BSX, MCK, SYK |
| Q3 2024 | 33 | $234.6M | XBI, LLY, THC, NVO, UHS |
| Q2 2024 | 37 | $223.9M | LLY, NVO, MCK, THC, BSX |
| Q1 2024 | 46 | $275.1M | XBI, LLY, NVO, BSX, TMO |